Skip to content

Allotment

KRM Ayurveda Limited

KRM Ayurveda Ltd. has filed its Draft Red Herring Prospectus (DRHP) with the exchange to raise funds through an Initial Public Offering (IPO).

The KRM Ayurveda Ltd. IPO is a book-built issue comprising only a fresh issue of up to 0.57 crore equity shares. The company proposes to list its equity shares on the NSE SME platform.

Nexgen Capitals Ltd. has been appointed as the book-running lead manager for the issue, while Skyline Financial Services Pvt. Ltd. is acting as the registrar. Key details such as the IPO dates, price band, and lot size are yet to be announced.

KRM Ayurveda Limited IPO & Charts
₹135

0%

Open

₹135

HIgh - Low

₹135

Previous Close

₹135

Total Traded Value

0

52 Weeks High

₹135

52 Weeks Low

₹135

Updates On

Jan 10, 2026

IPO. Open

Jan 21, 2026

IPO. Close

Jan 23, 2026

IPO. Price

₹135.00

IPO Market price

-

IPO Details

IPO Date 29 Jan
IPO Listing Date 29 Jan
IPO Face Value ₹10.00 per share
IPO Price Range ₹135.00
IPO Issue Size 57,40,000 shares
IPO Sale Type Fresh Capital
Employee Discount -
IPO Issue Type Bookbuilding IPO
IPO Listing NSE SME Platform
Share Holding Pre Issue 1,55,20,800 shares

IPO Timeline

IPO Open Date 21 Jan
IPO Close Date 23 Jan
IPO Allotment (Tentative) 27 Jan
Refunds 28 Jan
Credit to Demat Account 28 Jan
IPO Listing Date 29 Jan

IPO Reservation

Category Offer
QIB Shares Offered Not more than 50% of the Net Issue
NII (HNI) Shares Offered Not less than 35% of the Net Issue
Retail Shares Offered Not less than 15% of the Net Issue

IPO Lot Size

About Company

Incorporated on September 3, 2019, KRM Ayurveda Ltd. operates a network of hospitals and clinics across multiple cities in India and has also established its presence overseas through telemedicine consultations and product sales.

The company is engaged in the manufacturing of Ayurvedic products, including herbal and botanical remedies, medicines, supplements, and wellness and skincare-related items. Currently, KRM Ayurveda runs 6 hospitals and 5 clinics at various locations across the country.

Services and Products
Hospitals
Clinics
Teleconsultation services
KRM Ayurveda products

As of August 31, 2025, the company employs a total of 429 personnel across various departments.

Competitive Strengths
Highly skilled Ayurvedic physicians and certified therapists ensuring quality treatment.
Centralised GMP-certified manufacturing facility ensuring the purity and efficacy of Ayurvedic medicines.
A trusted brand supported by a loyal customer base and strong repeat clientele.

KRM Ayurveda Ltd. reported a 14% increase in revenue and a significant 255% growth in profit after tax (PAT) between the financial years ended March 31, 2024 and March 31, 2025.

Company Financials (Consolidated)

Assets 66.79 43.91 39.48
Total Income 76.95 67.57 89.38
Profit After Tax 12.1 3.41 7.6
EBITDA 19.11 7.34 11.03
NET Worth 23.88 11.78 8.37
Reserves and Surplus 23.73 11.63 8.22
Total Borrowing 31.2 23.18 19.87

Key Performance Indicator (KPI)

ROE 67.86%
ROCE 43.33%
Debt/Equity 1.31
RoNW 67.86%
PAT Margin 15.80%
EBITDA Margin 24.96%
Price to Book Value -
IPO Objective

IPO Objects of the Issue

S.No. Objects of the ipo Resources Detail IPO Amount
1 Funding capital expenditure requirements for the purchase of equipment/machineries 13.67
2 To meet out the expenses of Working Capital Requirement 18
3 To meet out the General Corporate Purposes; -
4 Offer for Sale (OFS) -

Contact Details

KRM Ayurveda Ltd. Address
A-16
G T Karnal road
North West Delhi, New Delhi, 110033
+91- 9289101700
compliance@krmayurveda.com
http://www.krmayurvedaindia.com/

Detail Registrar

IPO Registrar
Skyline Financial Services Pvt.Ltd.

02228511022
ipo@skylinerta.com
https://www.skylinerta.com/ipo.php

FAQ

The KRM Ayurveda Limited SME IPO opens on 19 January 2026 and closes on 21 January 2026, allowing investors three days to submit their applications.

The IPO is priced in a band of ₹128 to ₹135 per equity share, with a lot size of 1,000 shares, making it suitable for SME-focused investors.

KRM Ayurveda Limited proposes to list its equity shares on the NSE SME platform, providing investors exposure to a growing Ayurvedic healthcare company.

This is a 100% book-built IPO comprising a fresh issue of 57.40 lakh equity shares, aimed at raising growth capital for business expansion.

IPO funds will be used for telemedicine infrastructure, CRM systems, human resources, loan repayment, working capital needs, and general corporate purposes.

Compare:

Back To Top